GEM-4C 558 -4%
GPT-61S 555 -3.8%
CL-SN55 553 -3.8%
CL-OP55 551 -4%
GPT-61TERR 547 -3.5%
GEM-4CM 546 -4%
CL-OP55EH 542 -3.9%
GPT-61SOLXH 541 -3.6%
GPT-61SOLH 527 -3.7%
CL-SN55XH 523 -3.5%
GEM-4CL 520 -3.9%
GPT-61TERRXH 507 -3.4%
CL-OP55H 506 -4%
GPT-61SOLM 500 -3.5%
KIMI-K31P 499 -3.5%
GEM-4AR 498 -3.9%
GPT-61TERRH 490 -3.2%
CL-OP55M 483 -3.6%
MUSE-WONDFUL 479 -3.8%
CL-SN55H 467 -3.3%
CL-HK55 463 -2.9%
GPT-61TERRM 462 -3.1%
GPT-6A 451 -4.7%
MUSE-WOND 451 -3.6%
CL-HK55XH 450 -3%
GPT-6ASTRXH 440 -4.8%
GROK-47 440 -3.1%
GROK-47H 438 -2.9%
GPT-6ASTRH 437 -4.8%
DSK-V-340615 436 -2.9%
QWEN-38X 428 -2.9%
GPT-61SOLL 423 -3.2%
GLM-53 420 -3%
MIMO-V26P 420 -2.6%
CL-HK55H 419 -2.8%
LING-31F1019 417 -2.6%
GEM-38F 416 -2.8%
GPT-6ASTRM 415 -4.6%
MMAX-M31F 414 -2.8%
GEM-38FM 412 -2.8%
GPT-61TERRNO 411 -2.8%
GROK-47L 410 -2.8%
DSK-V-3E48BD 410 -2.6%
GPT-6L 407 -2.6%
GLM-53F 407 -2.6%
STEP-5 405 -2.6%
CL-FABL51XH 403 -4.7%
GPT-61TERRL 403 -2.9%
MIMO-V26F 401 -2.4%
CL-FABL51 399 -4.5%
CL-SN55M 395 -2.9%
CL-OP55L 393 -3.4%
MIST-LARG4 390 -2.7%
CL-FABL51H 386 -4.5%
CL-HK55M 386 -2.3%
GPT-6LUNAXH 377 -2.6%
MUSE-SPAROPE 375 -2.6%
MIST-LARG4M 371 -2.4%
DSK-V4P 365 -2.4%
GPT-6LUNAH 365 -2.1%
GLM-53L 364 -2.4%
CL-SN55L 362 -2.7%
GEM-38FL 361 -2.4%
GPT-6ASTRL 359 -4.5%
CL-FABL51M 359 -4.5%
QWEN-827B 349 -2.2%
CL-HK55L 347 -2%
MMAX-M3 345 -2%
GPT-6LUNAM 344 -2.3%
DSK-V-02811D 344 -2%
K2-HORI375BA 342 -2%
REFL-BEAM 338 -2%
QWEN-827BM 332 -1.8%
CL-FABL51L 329 -4.4%
QWEN-827BL 320 -1.8%
NEMO-35SUPEV 313 -1.9%
INKL 295 -1.7%
NVID-NEMO3UL 295 -1.3%
GEM-35FLITE 295 -1.3%
GPT-6LUNAL 287 -1.4%
GPT-6LUNANON 286 -1%
NANB-333B 285 -2.7%
QWEN-827BNON 282 -1.4%
COMM-APLUS 266 -1.1%
MUSE-GLIM 263 -1.1%
NEMO-35LIGH 261 -0.8%
GRAN-428B 258 -0.8%
MIST-SMAL4 252 -0.4%
INKL-SM 235 -2.5%
GEMM-431B 225 —
GEMM-4E4B 225 —
GEMM-4E4BNON 225 —
LING-30TINY 225 —
MINI-33B 225 —
NORT-MCODE 225 —
NOVA-MICR 225 —
NVID--ADE3B4 225 —
QWEN-54B 225 —
QWEN-54BNONR 225 —
TINY-AYAGLOB 225 —
GEM-4C 558 -4%
GPT-61S 555 -3.8%
CL-SN55 553 -3.8%
CL-OP55 551 -4%
GPT-61TERR 547 -3.5%
GEM-4CM 546 -4%
CL-OP55EH 542 -3.9%
GPT-61SOLXH 541 -3.6%
GPT-61SOLH 527 -3.7%
CL-SN55XH 523 -3.5%
GEM-4CL 520 -3.9%
GPT-61TERRXH 507 -3.4%
CL-OP55H 506 -4%
GPT-61SOLM 500 -3.5%
KIMI-K31P 499 -3.5%
GEM-4AR 498 -3.9%
GPT-61TERRH 490 -3.2%
CL-OP55M 483 -3.6%
MUSE-WONDFUL 479 -3.8%
CL-SN55H 467 -3.3%
CL-HK55 463 -2.9%
GPT-61TERRM 462 -3.1%
GPT-6A 451 -4.7%
MUSE-WOND 451 -3.6%
CL-HK55XH 450 -3%
GPT-6ASTRXH 440 -4.8%
GROK-47 440 -3.1%
GROK-47H 438 -2.9%
GPT-6ASTRH 437 -4.8%
DSK-V-340615 436 -2.9%
QWEN-38X 428 -2.9%
GPT-61SOLL 423 -3.2%
GLM-53 420 -3%
MIMO-V26P 420 -2.6%
CL-HK55H 419 -2.8%
LING-31F1019 417 -2.6%
GEM-38F 416 -2.8%
GPT-6ASTRM 415 -4.6%
MMAX-M31F 414 -2.8%
GEM-38FM 412 -2.8%
GPT-61TERRNO 411 -2.8%
GROK-47L 410 -2.8%
DSK-V-3E48BD 410 -2.6%
GPT-6L 407 -2.6%
GLM-53F 407 -2.6%
STEP-5 405 -2.6%
CL-FABL51XH 403 -4.7%
GPT-61TERRL 403 -2.9%
MIMO-V26F 401 -2.4%
CL-FABL51 399 -4.5%
CL-SN55M 395 -2.9%
CL-OP55L 393 -3.4%
MIST-LARG4 390 -2.7%
CL-FABL51H 386 -4.5%
CL-HK55M 386 -2.3%
GPT-6LUNAXH 377 -2.6%
MUSE-SPAROPE 375 -2.6%
MIST-LARG4M 371 -2.4%
DSK-V4P 365 -2.4%
GPT-6LUNAH 365 -2.1%
GLM-53L 364 -2.4%
CL-SN55L 362 -2.7%
GEM-38FL 361 -2.4%
GPT-6ASTRL 359 -4.5%
CL-FABL51M 359 -4.5%
QWEN-827B 349 -2.2%
CL-HK55L 347 -2%
MMAX-M3 345 -2%
GPT-6LUNAM 344 -2.3%
DSK-V-02811D 344 -2%
K2-HORI375BA 342 -2%
REFL-BEAM 338 -2%
QWEN-827BM 332 -1.8%
CL-FABL51L 329 -4.4%
QWEN-827BL 320 -1.8%
NEMO-35SUPEV 313 -1.9%
INKL 295 -1.7%
NVID-NEMO3UL 295 -1.3%
GEM-35FLITE 295 -1.3%
GPT-6LUNAL 287 -1.4%
GPT-6LUNANON 286 -1%
NANB-333B 285 -2.7%
QWEN-827BNON 282 -1.4%
COMM-APLUS 266 -1.1%
MUSE-GLIM 263 -1.1%
NEMO-35LIGH 261 -0.8%
GRAN-428B 258 -0.8%
MIST-SMAL4 252 -0.4%
INKL-SM 235 -2.5%
GEMM-431B 225 —
GEMM-4E4B 225 —
GEMM-4E4BNON 225 —
LING-30TINY 225 —
MINI-33B 225 —
NORT-MCODE 225 —
NOVA-MICR 225 —
NVID--ADE3B4 225 —
QWEN-54B 225 —
QWEN-54BNONR 225 —
TINY-AYAGLOB 225 —

Delayed ticker data. Last calculated 5 Nov 2026, 11:04 pm Sydney time.

← Back to feed

Ontario Audit: 12 of 20 Government-Approved AI Medical Scribes Got the Drug Wrong

Ontario’s Auditor General Shelley Spence released a special report on May 13 covering AI use across the provincial public service. The findings on medical AI scribes are the kind that make a procurement process look like it was designed to fail.

The province approved 20 vendors to supply AI transcription software to family doctors and other healthcare workers. Before approval, Supply Ontario ran two standardised test conversations between a simulated doctor and patient through each system. Here is what the tests found:

  • 12 of 20 systems captured a different drug than what the doctor prescribed
  • 9 of 20 systems fabricated information — referring patients for therapy, ordering blood tests, or suggesting clinical steps that were never mentioned in the recording
  • 17 of 20 systems missed key details about the patients’ mental health issues in at least one of the two tests

Eleven of the 20 approved vendors did not submit third-party audit reports, ISO 27001 certifications, or threat risk assessments during the procurement process. Five skipped threat risk assessments and privacy impact assessments. All were approved anyway.

The procurement weighting

Spence’s report details how Supply Ontario scored vendors:

CriterionWeight
Domestic presence in Ontario30%
Data privacy/legal controls23%
System security controls11%
Accuracy of medical notes4%

A vendor could score zero on accuracy, security controls, and bias mitigation and still clear the minimum threshold for approval. The auditor notes this explicitly.

Scale of deployment

The province says the systems save doctors five to seven hours of administrative work per week on average. Provincial Minister Stephen Crawford insisted the errors occurred during the testing phase, not live use, and that doctors review all AI-generated notes before acting on them. Auditor General Spence pushed back: she visited her own doctor during the audit and noticed they were using one of the approved AI scribes in a live appointment.

A privacy breach in September 2024, traced to an unapproved AI scribe in use at a hospital, preceded the province’s formal April 2025 rollout of the approved vendor list.

Spence made 10 recommendations. The province accepted nine. The one it rejected: increasing the weight given to security and privacy controls in future AI procurement scoring, which Supply Ontario said was “appropriate” as currently configured.

The accepted recommendations focus on mandatory doctor attestation that notes were reviewed, annual third-party audits in vendor contracts, and better risk assessment processes for procurement.

Context

Ontario is not the only jurisdiction running into this problem. A broader pattern has emerged across healthcare AI deployments: systems that perform well in controlled evaluations degrade substantially when variables include real patients, regional accents, medical terminology variation, and conversational context. The province approved 2024-era systems. Critics of the report, including some healthcare AI consultants, note that current-generation scribes have improved. The auditor’s position: the 2025 rollout used the results from those evaluations, and the evaluation process itself was the problem regardless of when the testing took place.

The structural issue — low accuracy weighting in procurement, vendors approved without security documentation — is a policy failure that will repeat unless the weighting changes.